Central Bucks Internal Medicine is categorized under Internal Medicine Doctors in Doylestown, PA and active since 1995.
Central Bucks Internal Medicine was established in 1995, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Bohdan Martinec at the company’s single location by writing to 301 South Main St # 2s, Doylestown, Pennsylvania PA 18901 or by phoning (215) 348-4478. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Bucks Internal Medicine |
| Contact Person: | Bohdan Martinec |
| Address: | 301 South Main St # 2s, Doylestown, Pennsylvania 18901 |
| Phone Number: | (215) 348-4478 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Central Bucks Internal Medicine was started in 1995 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Bohdan Martinec for inquiries that concern Central Bucks Internal Medicine by calling the company number (215) 348-4478, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Bucks Internal Medicine can be found at the coordinates 40.303782,-75.128609 as well as the street address 301 South Main St # 2s in Doylestown, Pennsylvania 18901.
For its online presence, you may visit Central Bucks Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.